Status: Finalised First registered on: 09/09/2015
Last updated on: 23/10/2018
1. Study identification
EU PAS Register NumberEUPAS10923
Official titleEffectiveness of prescribing similar vs dissimilar devices for COPD management (phase 2)
Study title acronym
Study typeObservational study
Brief description of the studyEffectiveness of prescribing similar vs dissimilar devices for COPD management (phase 2): − Compare the effectiveness (in terms of moderate and severe exacerbation prevention) of prescribing inhaler devices with similar inhalation techniques vs prescribing devices with dissimilar inhalation techniques in patients with COPD − Assess therapy adherence in patients with COPD prescribed inhaler devices with similar inhalation techniques vs patients prescribed devices with dissimilar inhalation techniques
Was this study requested by a regulator?Don't know
Is the study required by a Risk Management Plan (RMP)? Not applicable
Regulatory procedure number (RMP Category 1 and 2 studies only)
Other study registration identification numbers and URLs as applicable
2. Research centres and Investigator details
Coordinating study entity
Centre to which the investigator belongsOPRI Pte Ltd
Department/Research groupObservational and Pragmatic Research Institute Pte Ltd
Organisation/affiliationOPRI Pte Ltd
Website/Homepagewww.opri.sg
Details of (Primary) lead investigator
Title Professor
Last name Price
First name David
Is this study being carried out with the collaboration of a research network?
No
Other centres where this study is being conducted
Not applicable (single centre)

Countries in which this study is being conducted
National study

United Kingdom
3. Study timelines: initial administrative steps, progress reports and final report
PlannedActual
Date when funding contract was signed18/06/201508/04/2016
Start date of data collection28/08/201528/08/2015
Start date of data analysis14/09/2015
Date of interim report, if expected25/01/2016
Date of final study report08/02/201608/04/2016
4. Sources of funding
Please provide estimates of the percentage of funding by source for this study
Names(s)Approximate % funding
Pharmaceutical companiesTeva100
Charities
Government body
Research councils
EU funding scheme
5. Contact details for enquiries
Scientific Enquiries
Title Professor
Last name Price
First name David
Address line 1University of Aberdeen
Address line 2 
Address line 3 
CityAberdeen 
PostcodeAB24 3FX 
CountryUnited Kingdom
Phone number (incl. country code)441223967855 
Alternative phone number 
Fax number (incl. country code) 
Email address david@rirl.org
Public Enquiries
Title Professor 
Last name Price 
First name David 
Address line 1University of Aberdeen 
Address line 2 
Address line 3 
CityAberdeen 
PostcodeAB24 3FX 
CountryUnited Kingdom 
Phone number (incl. country code)441223967855 
Alternative phone number 
Fax number (incl. country code) 
Email address david@rirl.org 
Top